A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas’ disease
Trends in Parasitology · 2024
DOI: 10.1016/j.pt.2024.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Parasitology, 2024. Verfasst von Manuel Saldivia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Biomedical Research, Emeryville, CA, USA. Hauptthemen laut MEDLINE: Chagas Disease, Leishmaniasis, Trypanosomiasis, Leishmaniasis, Visceral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Novartis Biomedical Research, Emeryville, CA, USA.
- Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- York Biomedical Research Institute and Department of Biology, University of York, York, UK. Electronic address: jeremy.mottram@york.ac.uk.
Förderung
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Saldivia, M., Lima, A. P. C. A., & Mottram, J. C. (2024). A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas’ disease. Trends in Parasitology. https://doi.org/10.1016/j.pt.2024.02.002
Vancouver
Saldivia M, Lima APCA, Mottram JC. A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas’ disease. Trends in Parasitology. 2024. doi:10.1016/j.pt.2024.02.002
BibTeX
@article{Saldivia2024,
author = {Saldivia, Manuel and Lima, Ana Paula C A and Mottram, Jeremy C},
title = {A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas’ disease},
journal = {Trends in Parasitology},
year = {2024},
doi = {10.1016/j.pt.2024.02.002}
}
EUVIMED